Dominique Le Guludec
Overview
Explore the profile of Dominique Le Guludec including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
1497
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lafarge J, Aron-Wisnewsky J, Pattou F, Cucherat M, Blondet E, Lascols S, et al.
Diabetes Metab
. 2023 Nov;
50(1):101495.
PMID: 38000504
Objective: Randomized controlled trials (RCTs) have demonstrated the superiority of metabolic surgery (MS) over medical therapy (MT) in patients with obesity and type 2 diabetes, leading, to a joint statement...
2.
Vanier A, Fernandez J, Kelley S, Alter L, Semenzato P, Alberti C, et al.
BMJ Evid Based Med
. 2023 Feb;
29(1):1-5.
PMID: 36788020
No abstract available.
3.
4.
Le Guludec D, Czernin J, Calais J
J Nucl Med
. 2022 Mar;
63(3):327-330.
PMID: 35232878
No abstract available.
5.
Piekarski E, Mahida B, Rouzet F, Le Guludec D
J Nucl Cardiol
. 2020 Oct;
29(2):609-611.
PMID: 33057970
No abstract available.
6.
Piekarski E, Manrique A, Rouzet F, Le Guludec D
Semin Nucl Med
. 2020 Apr;
50(3):219-226.
PMID: 32284108
Myocardial perfusion imaging (MPI) with Single-Photon Emission Computed Tomography (SPECT) has a major role in the management of coronary artery disease. Recent technological advances regarding SPECT detectors with the use...
7.
Vigne J, Cabella C, Dezsi L, Rustique E, Couffin A, Aid R, et al.
Nanomedicine
. 2020 Jan;
25:102157.
PMID: 31982616
Nanostructured lipid carriers (NLC) might represent an interesting approach for the identification and targeting of rupture-prone atherosclerotic plaques. In this study, we evaluated the biodistribution, targeting ability and safety of...
8.
Vigne J, Bay S, Aid-Launais R, Pariscoat G, Rucher G, Senemaud J, et al.
Sci Rep
. 2019 Dec;
9(1):19560.
PMID: 31863037
There is a need for new targets to specifically localize inflammatory foci, usable in a wide range of organs. Here, we hypothesized that the cleaved molecular form of CD31 is...
9.
Chauvierre C, Aid-Launais R, Aerts J, Chaubet F, Maire M, Chollet L, et al.
Mar Drugs
. 2019 Dec;
17(12).
PMID: 31842319
The adhesion molecule P-selectin is present on the cell surface of both activated endothelium and activated platelets. The present study describes the pharmaceutical development, safety evaluation, and preclinical efficacy of...
10.
Calais J, Touati A, Grall N, Laouenan C, Benali K, Mahida B, et al.
Circ Cardiovasc Imaging
. 2019 Jul;
12(7):e007188.
PMID: 31291779
Background: Cardiac implantable electronic devices (CIEDs) chronic infection diagnosis is challenging because the clinical presentation is frequently misleading and echocardiography may be inconclusive. The aim of this study was to...